Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion.
[22q11.2 deletion syndrome]
Background
:
To
alert
for
the
diagnosis
of
the
22
q
11
.
2
deletion
syndrome
(
22
q
11
.
2
DS
)
in
patients
with
congenital
heart
disease
(
CHD
)
.
Objective
:
To
describe
the
main
CHDs
,
as
well
as
phenotypic
,
metabolic
and
immunological
findings
in
a
series
of
60
patients
diagnosed
with
22
q
11
.
2
DS
.
Methods
:
The
study
included
60
patients
with
22
q
11
.
2
DS
evaluated
between
2007
and
2013
(
M
:
F
=
1
.
3
,
age
range
14
days
to
20
years
and
3
months
)
at
a
pediatric
reference
center
for
primary
immunodeficiencies
.
The
diagnosis
was
established
by
detection
of
the
22
q
11
.
2
microdeletion
using
FISH
(
n
=
18
)
and
/
or
MLPA
(
n
=
42
)
,
in
association
with
clinical
and
laboratory
information
.
Associated
CHDs
,
progression
of
phenotypic
facial
features
,
hypocalcemia
and
immunological
changes
were
analyzed
.
Results
:
CHDs
were
detected
in
77
%
of
the
patients
and
the
most
frequent
type
was
tetralogy
of
Fallot
(
38
.
3
%
)
.
Surgical
correction
of
CHD
was
performed
in
34
patients
.
Craniofacial
dysmorphisms
were
detected
in
41
patients
:
elongated
face
(
60
%
)
and
/
or
elongated
nose
(
53
.
3
%
)
,
narrow
palpebral
fissure
(
50
%
)
,
dysplastic
,
overfolded
ears
(
48
.
3
%
)
,
thin
lips
(
41
.
6
%
)
,
elongated
fingers
(
38
.
3
%
)
and
short
stature
(
36
.
6
%
)
.
Hypocalcemia
was
detected
in
64
.
2
%
and
decreased
parathyroid
hormone
(
PTH
)
level
in
25
.
9
%
.
Decrease
in
total
lymphocytes
,
CD
4
and
CD
8
counts
were
present
in
40
%
,
53
.
3
%
and
33
.
3
%
,
respectively
.
Hypogammaglobulinemia
was
detected
in
one
patient
and
decreased
concentrations
of
immunoglobulin
M
(
IgM
)
in
two
other
patients
.
Conclusion
:
Suspicion
for
22
q
11
.
2
DS
should
be
raised
in
all
patients
with
CHD
associated
with
hypocalcemia
and
/
or
facial
dysmorphisms
,
considering
that
many
of
these
changes
may
evolve
with
age
.
The
22
q
11
.
2
microdeletion
should
be
confirmed
by
molecular
testing
in
all
patients
.
Diseases
Validation
Diseases presenting
"considering that many of these changes may evolve with age"
symptom
22q11.2 deletion syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom